Literature DB >> 9600118

Influence of drinking green tea on breast cancer malignancy among Japanese patients.

K Nakachi1, K Suemasu, K Suga, T Takeo, K Imai, Y Higashi.   

Abstract

Inhibitory effects of green tea on carcinogenesis have been investigated in numerous laboratory studies using (-)-epigallocatechin gallate (EGCG) or crude green tea extract, and there is also some epidemiologic evidence. Further, EGCG has been reported to inhibit the growth of cancer cells, lung metastasis in an animal model, and urokinase activity. In this study, we first examined the association between consumption of green tea prior to clinical cancer onset and various clinical parameters assessed at surgery among 472 patients with stage I, II, and III breast cancer. We found that increased consumption of green tea was closely associated with decreased numbers of axillary lymph node metastases among premenopausal patients with stage I and II breast cancer and with increased expression of progesterone receptor (PgR) and estrogen receptor (ER) among postmenopausal ones. Since these are potential prognostic factors, we then investigated the prognosis of breast cancer with special reference to consumption of green tea, in a follow-up study of these patients. We found that increased consumption of green tea was correlated with decreased recurrence of stage I and II breast cancer (P < 0.05 for crude disease-free survival); the recurrence rate was 16.7 or 24.3% among those consuming > or = 5 cups or < or = 4 cups per day, respectively, in a seven-year follow-up of stage I and II breast cancer, and the relative risk of recurrence was 0.564 (95% confidence interval, 0.350-0.911) after adjustment for other lifestyle factors. However, no improvement in prognosis was observed in stage III breast cancer. Our results indicate that increased consumption of green tea prior to clinical cancer onset is significantly associated with improved prognosis of stage I and II breast cancer, and this association may be related to a modifying effect of green tea on the clinical characteristics of the cancer.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9600118      PMCID: PMC5921805          DOI: 10.1111/j.1349-7006.1998.tb00556.x

Source DB:  PubMed          Journal:  Jpn J Cancer Res        ISSN: 0910-5050


(—)‐epigallocatechin gallate progesterone receptor estrogen receptor
  20 in total

1.  Why drinking green tea could prevent cancer.

Authors:  J Jankun; S H Selman; R Swiercz; E Skrzypczak-Jankun
Journal:  Nature       Date:  1997-06-05       Impact factor: 49.962

Review 2.  Japanese green tea as a cancer preventive in humans.

Authors:  H Fujiki; M Suganuma; S Okabe; A Komori; E Sueoka; N Sueoka; T Kozu; Y Sakai
Journal:  Nutr Rev       Date:  1996-11       Impact factor: 7.110

3.  Two promoters in expression of estrogen receptor messenger RNA in human breast cancer.

Authors:  S Hayashi; K Imai; K Suga; T Kurihara; Y Higashi; K Nakachi
Journal:  Carcinogenesis       Date:  1997-03       Impact factor: 4.944

4.  Abnormal FHIT transcripts in human breast carcinomas: a clinicopathological and epidemiological analysis of 61 Japanese cases.

Authors:  S Hayashi; K Tanimoto; K Hajiro-Nakanishi; E Tsuchiya; M Kurosumi; Y Higashi; K Imai; K Suga; K Nakachi
Journal:  Cancer Res       Date:  1997-05-15       Impact factor: 12.701

5.  Cancer-preventive effects of drinking green tea among a Japanese population.

Authors:  K Imai; K Suga; K Nakachi
Journal:  Prev Med       Date:  1997 Nov-Dec       Impact factor: 4.018

6.  The synthetic retinoid fenretinide lowers plasma insulin-like growth factor I levels in breast cancer patients.

Authors:  R Torrisi; F Pensa; M A Orengo; E Catsafados; P Ponzani; F Boccardo; A Costa; A Decensi
Journal:  Cancer Res       Date:  1993-10-15       Impact factor: 12.701

7.  Anticarcinogenic activity of green tea polyphenols.

Authors:  A Komori; J Yatsunami; S Okabe; S Abe; K Hara; M Suganuma; S J Kim; H Fujiki
Journal:  Jpn J Clin Oncol       Date:  1993-06       Impact factor: 3.019

8.  Polymorphisms of the CYP1A1 and glutathione S-transferase genes associated with susceptibility to lung cancer in relation to cigarette dose in a Japanese population.

Authors:  K Nakachi; K Imai; S Hayashi; K Kawajiri
Journal:  Cancer Res       Date:  1993-07-01       Impact factor: 12.701

9.  Effect of (-)-epigallocatechin gallate, the main constituent of green tea, on lung metastasis with mouse B16 melanoma cell lines.

Authors:  S Taniguchi; H Fujiki; H Kobayashi; H Go; K Miyado; H Sadano; R Shimokawa
Journal:  Cancer Lett       Date:  1992-07-31       Impact factor: 8.679

10.  Inhibition of N-methyl-N'-nitro-N-nitrosoguanidine-induced carcinogenesis by (-)-epigallocatechin gallate in the rat glandular stomach.

Authors:  T Yamane; T Takahashi; K Kuwata; K Oya; M Inagake; Y Kitao; M Suganuma; H Fujiki
Journal:  Cancer Res       Date:  1995-05-15       Impact factor: 12.701

View more
  58 in total

Review 1.  Phytochemicals in the oncology setting.

Authors:  Catherine E Ulbricht; Wendy Chao
Journal:  Curr Treat Options Oncol       Date:  2010-12

2.  Genetic Association Between the COMT Genotype and Urinary Levels of Tea Polyphenols and Their Metabolites among Daily Green Tea Drinkers.

Authors:  Maki Inoue-Choi; Jian-Min Yuan; Chung S Yang; David J Van Den Berg; Mao-Jung Lee; Yu-Tang Gao; Mimi C Yu
Journal:  Int J Mol Epidemiol Genet       Date:  2010

3.  In vitro and in vivo antitumorigenic activity of a mixture of lysine, proline, ascorbic acid, and green tea extract on human breast cancer lines MDA-MB-231 and MCF-7.

Authors:  M Waheed Roomi; Vadim Ivanov; Tatiana Kalinovsky; Aleksandra Niedzwiecki; Matthias Rath
Journal:  Med Oncol       Date:  2005       Impact factor: 3.064

Review 4.  Perspectives for cancer prevention with natural compounds.

Authors:  A R M Ruhul Amin; Omer Kucuk; Fadlo R Khuri; Dong M Shin
Journal:  J Clin Oncol       Date:  2009-05-04       Impact factor: 44.544

Review 5.  Tea and cancer prevention: epidemiological studies.

Authors:  Jian-Min Yuan; Canlan Sun; Lesley M Butler
Journal:  Pharmacol Res       Date:  2011-03-23       Impact factor: 7.658

6.  In vitro mechanism for downregulation of ER-α expression by epigallocatechin gallate in ER+/PR+ human breast cancer cells.

Authors:  Francesca De Amicis; Alessandra Russo; Paola Avena; Marta Santoro; Adele Vivacqua; Daniela Bonofiglio; Loredana Mauro; Saveria Aquila; Donatella Tramontano; Suzanne A W Fuqua; Sebastiano Andò
Journal:  Mol Nutr Food Res       Date:  2013-01-16       Impact factor: 5.914

Review 7.  Cancer preventive mechanisms of the green tea polyphenol (-)-epigallocatechin-3-gallate.

Authors:  Lei Chen; Hong-Yu Zhang
Journal:  Molecules       Date:  2007-05-03       Impact factor: 4.411

8.  Is green tea drinking associated with a later onset of breast cancer?

Authors:  Qi Dai; Xiao-Ou Shu; Honglan Li; Gong Yang; Martha J Shrubsole; Hui Cai; Butian Ji; Wanqing Wen; Adrian Franke; Yu-Tang Gao; Wei Zheng
Journal:  Ann Epidemiol       Date:  2010-01       Impact factor: 3.797

9.  Green tea intake, MTHFR/TYMS genotype and breast cancer risk: the Singapore Chinese Health Study.

Authors:  Maki Inoue; Kim Robien; Renwei Wang; David J Van Den Berg; Woon-Puay Koh; Mimi C Yu
Journal:  Carcinogenesis       Date:  2008-07-31       Impact factor: 4.944

Review 10.  Plant-Derived Natural Products in Cancer Research: Extraction, Mechanism of Action, and Drug Formulation.

Authors:  Wamidh H Talib; Izzeddin Alsalahat; Safa Daoud; Reem Fawaz Abutayeh; Asma Ismail Mahmod
Journal:  Molecules       Date:  2020-11-14       Impact factor: 4.411

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.